Filter
674
Filtered Results: 674
Text search:
Emergency
Use
Authorization
Featured
Recommendations
79
New Publications
153
Language
Document type
No document type
289
Guidelines
154
Studies & Reports
116
Manuals
39
Strategic & Response Plan
30
Fact sheets
25
Training Material
13
Situation Updates
5
Resource Platforms
2
Videos
1
Countries / Regions
Global
25
Kenya
24
India
21
Myanmar / Burma
19
Western and Central Europe
17
South Africa
15
Latin America and the Carribbean
14
Nigeria
13
Ghana
12
Sierra Leone
11
Liberia
11
Africa
11
Germany
10
Rwanda
10
Congo, Democratic Republic of
9
Syria
9
Bangladesh
9
Uganda
8
Nepal
8
Eastern Europe and Central Asia
8
Haiti
7
South Sudan
7
Malawi
7
East and Southern Africa
7
West and Central Africa
7
Cameroon
6
Namibia
6
Brazil
6
Russia
6
Ethiopia
5
Zimbabwe
5
Ecuador
5
Middle East and North Africa
5
Guinea
4
Senegal
4
Zambia
4
Tanzania
4
Eswatini/ Swaziland
4
Ukraine
4
Venezuela
4
Eastern Europe
4
Philippines
3
Cambodia
3
Lesotho
3
Yemen
3
Mali
2
Pakistan
2
Afghanistan
2
Thailand
2
Indonesia
2
Mozambique
2
Central African Republic
2
Peru
2
Colombia
2
South–East Asia Region
2
Paraguay
2
Laos
2
Burkina Faso
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Iraq
1
Chad
1
Gambia
1
North Macedonia
1
Serbia
1
Bolivia
1
Libya
1
Angola
1
Chile
1
Asia
1
Bhutan
1
Palestine
1
Albania
1
Armenia
1
Tajikistan
1
Moldova
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Vietnam
1
Maldives
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
251
Clinical Guidelines
43
Key Resources
42
Women & Child Health
29
Public Health
26
Pharmacy & Technologies
17
Capacity Building
5
Toolboxes
COVID-19
178
Rapid Response
33
Pharmacy
30
Conflict
28
HIV
25
Ebola
24
Refugee
20
AMR
18
Mental Health
16
Caregiver
14
TB
13
Natural Hazards
12
Planetary Health
12
Specific Hazards
8
Global Health Education
6
Health Financing Toolbox
6
NCDs
6
Zika
5
Disability
4
Cholera
3
Polio
2
Typhoon
1
Social Ethics
1
NTDs
1
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic...
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...
Rapid Assessment Guide for Psychosocial Support and Violence Prevention in Emergencies and Recovery
recommended
This guide provides standards and directions on how to carry out rapid needs assessment for Psychosocial Support (PSS) and Violence Prevention (VP) initiatives including child protection and sexual and gender-based violence. In particular, this rapid assessment tool is designed to help gather data i...
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient ...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the ... of COVID-19 simulation exercises to test deployment strategies;
the indemnity agreement and no-fault compensation programme for vaccines secured through the COVAX Facility in the Advance Market Commitment (AMC) eligible economies;
the availability and use of the WHO-UNICEF COVID-19 Vaccine Introduction and deployment Costing (CVIC) tool;
the COVAX Facility’s humanitarian buffer that enables allocation of vaccine to cover high-risk populations in humanitarian settings;
recommendations for vaccination of pregnant and lactating women;
supplementary information on infection prevention and control (IPC) measures to be used to deliver COVID-19 vaccines safely;
the WHO licensed COVID-19 vaccines product-specific information;
use of geospatial data and digital micro plans for equitable access and delivery of COVID-19 vaccines;
lessons learned from the development of NDVPs and early experiences in COVID-19 vaccine deployment in countries; and
updated additional resources at the end of each chapter.
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blocke...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of ..., the manual is available in a compiled form and in several separate modules that can be consulted individually. For each module, specific training material is also available to facilitate implementation.
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for...
Third edition.
The main changes within the third edition of the JEE tool include the split of the technical area National legislation, policy, and financing into two technical areas (Legal instruments and Financing); the drop of the technical area previously titled Reporting and the move of indicat...
This publication provides guidance to governments, civil society organizations (nongovernmental organizations and community-based organizations) and other partners implementing HIV prevention, care and treatment programs with key populations. This guide is designed to assist these programs in the de...
The global COVID-19 pandemic has led to unprecedented levels of disruption to education, impacting over 90% of the world’s student population: 1.54 billion children, including 743 million girls. School closures and the wider socio-economic impacts of COVID-19 on communities and society also disrup...
This handbook is intended primarily for front-line health care providers who are likely to see children (among other clients) in their day-to-day practice. These may include general practitioners, nurses, midwives, gynaecologists,
paediatricians, mental health professionals, first responders and st...
Through technical consultations with countries and partners, WHO has led the development of Preparedness and Resilience for Emerging Threats Module 1: Planning for respiratory pathogen pandemics. Version 1.0. The Module, currently available as an advanced draft, builds on previous pandemic lessons a...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi...
The goal of the global outbreak response for monkeypox is to stop human-to-human transmission of monkeypox, with a priority focus on communities at high risk of exposure which may differ according to context, and to effectively use strong public hea...
Options for the decontamination and reuse of respirators in the context of the COVID-19 pandemic
recommended
Guiding principles for reuse are:
Respirators which have been visibly contaminated (e.g. during procedure at intubated patients, such as suction cleaning of airways, taking probes, extubation attempts, etc.) or are damaged or not fitting, should be discarded and cannot be taken for re-... or decontamination procedures.
Respirators may be protected by a medical face mask in order to prevent soiling.
Use of new ‘expired respirators’ (manufacturers expiry date) is possible if they were properly stored until use.
